NYU-Langone — New York, New York

NYU-Langone is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

NYU-Langone has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Lymphoblastic Leukemia, Acute, Adult, B Cell ALL, Obesity.

Sponsors: Autolus Limited, Fractyl Health Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU-Langone?

NYU-Langone has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU-Langone conducted?

NYU-Langone has 2 clinical trials on record, with 1 currently active. Their work covers Lymphoblastic Leukemia, Acute, Adult, B Cell ALL, Obesity.

Is NYU-Langone accredited by Crixeo Health?

NYU-Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU-Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.